R01 NS030245/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2008	2
2009	1
2010	1
2025	0

Page 1

BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

Bacolod MD, Fehdrau R, Johnson SP, Bullock NS, Bigner DD, Colvin M, Friedman HS. Bacolod MD, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):753-8. doi: 10.1007/s00280-008-0792-9. Epub 2008 Jul 17. Cancer Chemother Pharmacol. 2009. PMID: 18633619 Free PMC article.

Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells.

Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS. Cui B, et al. J Biomed Res. 2010 Nov;24(6):424-35. doi: 10.1016/S1674-8301(10)60057-7. J Biomed Res. 2010. PMID: 23554659 Free PMC article.

Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

Maxwell JA, Johnson SP, McLendon RE, Lister DW, Horne KS, Rasheed A, Quinn JA, Ali-Osman F, Friedman AH, Modrich PL, Bigner DD, Friedman HS. Maxwell JA, et al. Clin Cancer Res. 2008 Aug 1;14(15):4859-68. doi: 10.1158/1078-0432.CCR-07-4807. Clin Cancer Res. 2008. PMID: 18676759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year